CTA - caption
All blocks test page
Page cards
Diagnosis and treatment
Learn about how macular disease is diagnosed. The optometrist at your local optician’s practice can test sight, prescribe glasses and check for early signs of eye disease using photography or other imaging. It is important to get your eyes checked at least every two years.
Support for you
We provide free information and support to those with macular disease, along with their family and friends, to help people keep their independence.
Downloads list
Image wrap left
Image wrap right
Pull quote
name
Pull quote
name
Title related articles
Befriending service renamed in memory of Marilyn Lee following £1m gift
Posted: Tuesday 23 June 2026
The Macular Society’s befriending service, which offers vital connection and friendship to those living with sight loss, has been renamed in memory of Marilyn Lee who received support after being diagnosed with macular disease.
Generous donations to remember our loved ones
Posted: Monday 29 December 2025
Alongside resolutions and well wishes, the New Year is also often a time to remember those who are no longer with us.
Grandsons cycle 44km for grandma, raising £1,000 to Beat Macular Disease
Posted: Friday 19 December 2025
A grandmother has spoken of her pride after her grandsons, aged just 10 and 12 cycled more than 40km to raise more than £1,000 for macular research on her behalf.
CTA btn
CTA btn
Professor Andrew Lotery answers your questions
Posted: Wednesday 5 March 2025
Professor Andrew Lotery discusses the latest approved treatment for wet age-related macular degeneration (AMD), Lytenava and answers your frequently asked questions on treatments and research.
Find out more
Gene therapy trial improves sight in blind toddlers
Posted: Tuesday 4 March 2025
Four toddlers born with a severe form of childhood blindness have experienced “life-changing improvements” to their sight after participating in an experimental gene therapy trial.
Find out more
Syfovre FAQs and next steps for dry AMD and geographic atrophy treatment
Posted: Thursday 30 January 2025
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) decision to reject the first potential treatment for geographic atrophy (GA), or late-stage age-related macular degeneration (AMD) is undoubtedly a disappointing one for those living with the condition. But, what does the decision mean? We answer your questions.
Find out more
People container
Upper text
upper text
lower text
Lower test
Image cards without links
Pizza 1
Pizza 2